Returning to work after a more than six-week absence because of June 2 surgery for prostate cancer has been gratifying, rewarding, humbling, and eye-opening. It feels familiar and foreign at the same ...
"The nurse, as I was leaving - I was literally opening the door - said 'oh by the way, and you do know you have prostate ...
Prostate cancer shows subtle symptoms in early stages, which makes detecting it difficult. Dr Singh highlights red flags to ...
Dominick Occhicone, convicted of killing his ex-fiancée's parents in 1986, is on schedule to become the oldest man ever ...
Michael will discuss second quarter 2026 financial results and corporate highlights. Lindsey will then provide details on financial performance and overall outlook for the year. This will be followed ...
Free Malaysia Today on MSN
Loh keeps learning, 4 decades and 1,000 robotic operations later
Veteran urologist Dr Loh Chit Sin reflects on his years in the field, the rise of machine-assisted surgery, and why precision matters more than ever.
Officials under President Donald Trump want to make it easier for men to get a prescription for testosterone, the latest ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time. The FDA approved capivasertib, sold as Truqap by AstraZeneca, on June 12, ...
The movements of a surgeon in a procedure—called "surgical gestures"—can be used to predict patient recovery, according to ...
Doctors say prostate cancer cases are rising across smaller towns and neighbouring states, but delayed diagnosis continues to ...
Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results